CD44 as a molecular marker to screen cancer stem cells in hypopharyngeal cancer

Acta Oto-Laryngologica

Volumn 133, Issue 11, 2013, Pages 1219-1226

  Shen, Chenling ^a   Xiang, Mingliang ^a   Nie, Chen ^a   Hu, Haixia ^a   Ma, Yan ^a   Wu, Hao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Biological marker; Cell surface marker; Hypopharyngeal carcinoma; MACS; NOD SCID; Tumor stem cell

Indexed keywords

HERMES ANTIGEN; MOLECULAR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER SCREENING; CANCER STEM CELL; CARCINOGENICITY; CELL POPULATION; CELL SELECTION; FLOW CYTOMETRY; HYPOPHARYNX CANCER; IN VITRO STUDY; INCUBATION TIME; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME;

ANIMALS; ANTIGENS, CD44; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 84885931516     PISSN: 00016489     EISSN: 16512251     Source Type: Journal    
DOI: 10.3109/00016489.2013.811750     Document Type: Article

References (18)

1. Hirose H, Yamamoto H, Miyoshi N, Uemura M, Miyazaki S. Takahashi H, et a1. Cancer stem cells in solid tumors. Gan To Kagaku Ryoho 2010;37:2809-12.
2. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003;63:5821-8.
3. Barreyro L, Will B, Bartholdy B, Zhou L, Todorova TI, Stanley RF, et al. Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS. Blood 2012;120:1290-8.
4. La Porta CA. Thoughts about cancer stem cells in solid tumors. World J Stem Cells 2012;4:17-20.
5. Wei XD, Zhou L, Cheng L, Tian J. Investigation of CD133 as putative marker of tumor-initiating cell in laryngeal carcinoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2007;42:692-6.
6. Karimi-Busheri F, Zadorozhny V, Li T, Lin H, Shawler DL, Fakhrai H. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells. J Stem Cells 2011;6: 9-20.
7. A1-Hajj M, Wicha MS, Benito-Hemandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cell. Proc Natl Acad Sci USA 2003;100: 3983-8.
8. Haraguchi N, Ohkuma M, Sakashita H, Matsuzaki S, Tanaka F, Mimori K, et al. CD133+CD44+ population efficiently enriches colon cancer initiating cells. Ann Surg Oncol 2008;15:2927-33.
9. Du L, Wang H, He L, Zhang J, Ni B, Wang X, et al. CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 2008;14:6751-60.
10. Hwang-Verslues WW, Kuo WH, Chang PH, Pan CC, Wang HH, Tsai ST, et al. Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. PLoS ONE 2009;4:e8377.
11. Smith SM, Cai L. Cell specific CD44 expression in breast cancer requires the interaction of AP-1 and NFkB with a novel cis-element. PLoS One 2012;7:e50867.
12. Wang SJ, Wong G, de Heer AM, Xia W, Bourguignon LY. CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope 2009;119:1518-30.
13. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007;104:10158-63.
14. Wang C, Xie J, Guo J, Manning HC, Gore JC, Guo N. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer. Oncol Rep 2012;28:1301-8.
15. Simon RA, di Sant'Agnese PA, Huang LS, Xu H, Yao JL, Yang Q, et al. CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers. Hum Pathol 2009;40:252.
16. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R, et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009; 27:1006-20.
17. Perez A, Neskey DM, Wen J, Pereira L, Reategui EP, Goodwin WJ, et al. CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression. Oral Oncol 2013;49:306-13.
18. PrinceME, SivanandanR,KaczorowskiA,WolfGT,KaplanMJ, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007;104:973-8.